- Zacks•20 hours ago
Seattle Genetics (SGEN) reported a loss of 23 cents per share, narrower than both the Zacks Consensus Estimate of a loss of 33 cents.
- Capital Cube•2 days ago
Click here to see latest analysisTakeda Pharmaceutical Co., Ltd. reports financial results for the year ended March 31, 2016.We analyze the earnings along side the following peers of Takeda Pharmaceutical Co., Ltd. – Johnson & Johnson and Novartis AG Sponsored ADR (JNJ-US and NVS-US) that have also reported for this period.HighlightsGross margins widened from 63.81% […] (Read more...) The post Takeda Pharmaceutical Co., Ltd. :TKPYY-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 appeared first on CapitalCube.
Takeda Pharmaceutical Company LimitedOther OTC
|52wk Range||20.32 - 26.52|
|Day's Range||21.37 - 21.80|
|Avg Vol (3m)||64,901|
As of 3:59 PM EDT. Market closed.